GO:0006413 | translational initiation | 6.47e-12 | 6.32e-08 | 6.402 | 6 | 12 | 99 |
GO:0006412 | translation | 3.88e-08 | 3.79e-04 | 5.292 | 5 | 13 | 178 |
GO:0015935 | small ribosomal subunit | 4.95e-08 | 4.83e-04 | 8.446 | 3 | 4 | 12 |
GO:0022627 | cytosolic small ribosomal subunit | 9.08e-07 | 8.87e-03 | 7.124 | 3 | 6 | 30 |
GO:0044267 | cellular protein metabolic process | 1.17e-06 | 1.14e-02 | 4.309 | 5 | 13 | 352 |
GO:0003743 | translation initiation factor activity | 1.73e-06 | 1.69e-02 | 6.822 | 3 | 5 | 37 |
GO:0019083 | viral transcription | 7.98e-06 | 7.79e-02 | 6.100 | 3 | 7 | 61 |
GO:0006415 | translational termination | 8.79e-06 | 8.59e-02 | 6.054 | 3 | 7 | 63 |
GO:0010467 | gene expression | 9.28e-06 | 9.07e-02 | 3.705 | 5 | 17 | 535 |
GO:0006414 | translational elongation | 1.16e-05 | 1.13e-01 | 5.922 | 3 | 7 | 69 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.61e-05 | 1.58e-01 | 5.764 | 3 | 7 | 77 |
GO:0019058 | viral life cycle | 1.68e-05 | 1.64e-01 | 5.746 | 3 | 8 | 78 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.10e-05 | 2.05e-01 | 5.639 | 3 | 7 | 84 |
GO:0042274 | ribosomal small subunit biogenesis | 2.42e-05 | 2.36e-01 | 7.987 | 2 | 3 | 11 |
GO:0003735 | structural constituent of ribosome | 4.58e-05 | 4.48e-01 | 5.263 | 3 | 8 | 109 |
GO:0008135 | translation factor activity, nucleic acid binding | 4.60e-05 | 4.50e-01 | 7.539 | 2 | 4 | 15 |
GO:0016071 | mRNA metabolic process | 1.72e-04 | 1.00e+00 | 4.622 | 3 | 11 | 170 |
GO:0016070 | RNA metabolic process | 2.32e-04 | 1.00e+00 | 4.476 | 3 | 11 | 188 |
GO:0002183 | cytoplasmic translational initiation | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0022605 | oogenesis stage | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0006364 | rRNA processing | 9.53e-04 | 1.00e+00 | 5.380 | 2 | 5 | 67 |
GO:0044822 | poly(A) RNA binding | 1.27e-03 | 1.00e+00 | 2.804 | 4 | 25 | 799 |
GO:0016032 | viral process | 2.56e-03 | 1.00e+00 | 3.290 | 3 | 13 | 428 |
GO:0019082 | viral protein processing | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0005829 | cytosol | 3.09e-03 | 1.00e+00 | 1.965 | 5 | 33 | 1787 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.27e-03 | 1.00e+00 | 4.480 | 2 | 6 | 125 |
GO:0000028 | ribosomal small subunit assembly | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 3 | 5 |
GO:0002309 | T cell proliferation involved in immune response | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0006924 | activation-induced cell death of T cells | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 2 | 6 |
GO:0075733 | intracellular transport of virus | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 2 | 7 |
GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0019068 | virion assembly | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0007067 | mitotic nuclear division | 5.64e-03 | 1.00e+00 | 4.080 | 2 | 5 | 165 |
GO:0031929 | TOR signaling | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 9 |
GO:0032479 | regulation of type I interferon production | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 9 |
GO:0043968 | histone H2A acetylation | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 10 |
GO:0016282 | eukaryotic 43S preinitiation complex | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:0033290 | eukaryotic 48S preinitiation complex | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:0043065 | positive regulation of apoptotic process | 8.35e-03 | 1.00e+00 | 3.788 | 2 | 3 | 202 |
GO:0035267 | NuA4 histone acetyltransferase complex | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 12 |
GO:0031369 | translation initiation factor binding | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 13 |
GO:0048821 | erythrocyte development | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 2 | 13 |
GO:0005852 | eukaryotic translation initiation factor 3 complex | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 13 |
GO:0001731 | formation of translation preinitiation complex | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 14 |
GO:0005978 | glycogen biosynthetic process | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 15 |
GO:0007220 | Notch receptor processing | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 1 | 16 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 17 |
GO:0007369 | gastrulation | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 1 | 17 |
GO:0005844 | polysome | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 1 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.35e-02 | 1.00e+00 | 6.198 | 1 | 4 | 19 |
GO:0032480 | negative regulation of type I interferon production | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 20 |
GO:0043967 | histone H4 acetylation | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 2 | 22 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 1 | 22 |
GO:0007093 | mitotic cell cycle checkpoint | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 25 |
GO:0001890 | placenta development | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 26 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 26 |
GO:0033077 | T cell differentiation in thymus | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 26 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 2 | 28 |
GO:0016197 | endosomal transport | 1.99e-02 | 1.00e+00 | 5.639 | 1 | 1 | 28 |
GO:0043066 | negative regulation of apoptotic process | 2.04e-02 | 1.00e+00 | 3.115 | 2 | 6 | 322 |
GO:0006446 | regulation of translational initiation | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 2 | 29 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.20e-02 | 1.00e+00 | 5.492 | 1 | 1 | 31 |
GO:0007254 | JNK cascade | 2.41e-02 | 1.00e+00 | 5.359 | 1 | 1 | 34 |
GO:0044297 | cell body | 2.48e-02 | 1.00e+00 | 5.317 | 1 | 1 | 35 |
GO:0005515 | protein binding | 2.53e-02 | 1.00e+00 | 1.021 | 6 | 50 | 4124 |
GO:0030666 | endocytic vesicle membrane | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 1 | 36 |
GO:0040008 | regulation of growth | 2.62e-02 | 1.00e+00 | 5.237 | 1 | 1 | 37 |
GO:0051403 | stress-activated MAPK cascade | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 2 | 42 |
GO:0032481 | positive regulation of type I interferon production | 3.39e-02 | 1.00e+00 | 4.861 | 1 | 1 | 48 |
GO:0034146 | toll-like receptor 5 signaling pathway | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 50 |
GO:0034166 | toll-like receptor 10 signaling pathway | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 50 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.67e-02 | 1.00e+00 | 4.746 | 1 | 3 | 52 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 3.74e-02 | 1.00e+00 | 4.718 | 1 | 1 | 53 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.74e-02 | 1.00e+00 | 4.718 | 1 | 3 | 53 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 2 | 55 |
GO:0034162 | toll-like receptor 9 signaling pathway | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 2 | 55 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 2 | 55 |
GO:0034134 | toll-like receptor 2 signaling pathway | 3.95e-02 | 1.00e+00 | 4.639 | 1 | 2 | 56 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.95e-02 | 1.00e+00 | 4.639 | 1 | 3 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 4.02e-02 | 1.00e+00 | 4.613 | 1 | 3 | 57 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 4.02e-02 | 1.00e+00 | 4.613 | 1 | 2 | 57 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 4.09e-02 | 1.00e+00 | 4.588 | 1 | 2 | 58 |
GO:0034138 | toll-like receptor 3 signaling pathway | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 2 | 59 |
GO:0042593 | glucose homeostasis | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 60 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 3 | 60 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 2 | 61 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 3 | 61 |
GO:0000187 | activation of MAPK activity | 4.43e-02 | 1.00e+00 | 4.469 | 1 | 2 | 63 |
GO:0016020 | membrane | 4.49e-02 | 1.00e+00 | 1.794 | 3 | 25 | 1207 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 3 | 65 |
GO:0050852 | T cell receptor signaling pathway | 4.78e-02 | 1.00e+00 | 4.359 | 1 | 1 | 68 |
GO:0005200 | structural constituent of cytoskeleton | 4.78e-02 | 1.00e+00 | 4.359 | 1 | 4 | 68 |
GO:0006325 | chromatin organization | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 2 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 4 | 70 |
GO:0016363 | nuclear matrix | 5.12e-02 | 1.00e+00 | 4.256 | 1 | 2 | 73 |
GO:0034142 | toll-like receptor 4 signaling pathway | 5.12e-02 | 1.00e+00 | 4.256 | 1 | 2 | 73 |
GO:0071456 | cellular response to hypoxia | 5.32e-02 | 1.00e+00 | 4.198 | 1 | 1 | 76 |
GO:0006006 | glucose metabolic process | 5.60e-02 | 1.00e+00 | 4.124 | 1 | 2 | 80 |
GO:0030529 | ribonucleoprotein complex | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 3 | 82 |
GO:0097190 | apoptotic signaling pathway | 5.80e-02 | 1.00e+00 | 4.071 | 1 | 1 | 83 |
GO:0002224 | toll-like receptor signaling pathway | 5.80e-02 | 1.00e+00 | 4.071 | 1 | 2 | 83 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 6.21e-02 | 1.00e+00 | 3.970 | 1 | 1 | 89 |
GO:0061024 | membrane organization | 6.21e-02 | 1.00e+00 | 3.970 | 1 | 3 | 89 |
GO:0000209 | protein polyubiquitination | 6.41e-02 | 1.00e+00 | 3.922 | 1 | 3 | 92 |
GO:0007219 | Notch signaling pathway | 6.62e-02 | 1.00e+00 | 3.876 | 1 | 2 | 95 |
GO:0034220 | ion transmembrane transport | 6.68e-02 | 1.00e+00 | 3.861 | 1 | 1 | 96 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.75e-02 | 1.00e+00 | 3.846 | 1 | 3 | 97 |
GO:0008286 | insulin receptor signaling pathway | 6.75e-02 | 1.00e+00 | 3.846 | 1 | 2 | 97 |
GO:0010008 | endosome membrane | 7.09e-02 | 1.00e+00 | 3.774 | 1 | 1 | 102 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 7.42e-02 | 1.00e+00 | 3.705 | 1 | 2 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 7.49e-02 | 1.00e+00 | 3.691 | 1 | 1 | 108 |
GO:0042981 | regulation of apoptotic process | 7.76e-02 | 1.00e+00 | 3.639 | 1 | 4 | 112 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 7.89e-02 | 1.00e+00 | 3.613 | 1 | 1 | 114 |
GO:0008022 | protein C-terminus binding | 7.96e-02 | 1.00e+00 | 3.601 | 1 | 1 | 115 |
GO:0003924 | GTPase activity | 8.23e-02 | 1.00e+00 | 3.551 | 1 | 3 | 119 |
GO:0006184 | GTP catabolic process | 8.96e-02 | 1.00e+00 | 3.424 | 1 | 3 | 130 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 9.09e-02 | 1.00e+00 | 3.402 | 1 | 1 | 132 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 9.75e-02 | 1.00e+00 | 3.296 | 1 | 3 | 142 |
GO:0070062 | extracellular vesicular exosome | 9.77e-02 | 1.00e+00 | 1.351 | 3 | 28 | 1641 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.10e-01 | 1.00e+00 | 3.115 | 1 | 3 | 161 |
GO:0030425 | dendrite | 1.13e-01 | 1.00e+00 | 3.071 | 1 | 3 | 166 |
GO:0019221 | cytokine-mediated signaling pathway | 1.17e-01 | 1.00e+00 | 3.020 | 1 | 4 | 172 |
GO:0005654 | nucleoplasm | 1.25e-01 | 1.00e+00 | 1.671 | 2 | 16 | 876 |
GO:0005975 | carbohydrate metabolic process | 1.26e-01 | 1.00e+00 | 2.907 | 1 | 1 | 186 |
GO:0005525 | GTP binding | 1.33e-01 | 1.00e+00 | 2.824 | 1 | 3 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.34e-01 | 1.00e+00 | 2.809 | 1 | 2 | 199 |
GO:0006281 | DNA repair | 1.37e-01 | 1.00e+00 | 2.781 | 1 | 2 | 203 |
GO:0019901 | protein kinase binding | 1.55e-01 | 1.00e+00 | 2.588 | 1 | 8 | 232 |
GO:0003723 | RNA binding | 1.64e-01 | 1.00e+00 | 2.498 | 1 | 6 | 247 |
GO:0006351 | transcription, DNA-templated | 1.75e-01 | 1.00e+00 | 1.375 | 2 | 15 | 1076 |
GO:0005925 | focal adhesion | 1.86e-01 | 1.00e+00 | 2.306 | 1 | 12 | 282 |
GO:0000278 | mitotic cell cycle | 2.05e-01 | 1.00e+00 | 2.151 | 1 | 9 | 314 |
GO:0055085 | transmembrane transport | 2.13e-01 | 1.00e+00 | 2.084 | 1 | 1 | 329 |
GO:0048471 | perinuclear region of cytoplasm | 2.22e-01 | 1.00e+00 | 2.020 | 1 | 7 | 344 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.41e-01 | 1.00e+00 | 1.888 | 1 | 6 | 377 |
GO:0006915 | apoptotic process | 2.60e-01 | 1.00e+00 | 1.763 | 1 | 4 | 411 |
GO:0045087 | innate immune response | 2.82e-01 | 1.00e+00 | 1.626 | 1 | 6 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.85e-01 | 1.00e+00 | 1.613 | 1 | 6 | 456 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 3.50e-01 | 1.00e+00 | 1.261 | 1 | 9 | 582 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.80e-01 | 1.00e+00 | 1.115 | 1 | 8 | 644 |
GO:0044281 | small molecule metabolic process | 4.69e-01 | 1.00e+00 | 0.725 | 1 | 8 | 844 |
GO:0046872 | metal ion binding | 5.05e-01 | 1.00e+00 | 0.579 | 1 | 10 | 934 |
GO:0003677 | DNA binding | 5.10e-01 | 1.00e+00 | 0.559 | 1 | 12 | 947 |
GO:0005730 | nucleolus | 6.06e-01 | 1.00e+00 | 0.197 | 1 | 21 | 1217 |
GO:0005886 | plasma membrane | 7.57e-01 | 1.00e+00 | -0.355 | 1 | 13 | 1784 |
GO:0005737 | cytoplasm | 8.89e-01 | 1.00e+00 | -0.916 | 1 | 39 | 2633 |
GO:0005634 | nucleus | 9.41e-01 | 1.00e+00 | -1.218 | 1 | 40 | 3246 |